|
1
|
Wang J, Yu JC, Kang WM and Ma ZQ:
Treatment strategy for early gastric cancer. Surg Oncol.
21:119–123. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Marqués-Lespier JM, González-Pons M and
Cruz-Correa M: Current perspectives on gastric cancer.
Gastroenterol Clin North Am. 45:413–428. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Thrumurthy SG, Chaudry MA, Chau I and
Allum W: Does surgery have a role in managing incurable gastric
cancer? Nat Rev Clin Oncol. 12:676–682. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
McLean MH and El-Omar EM: Genetics of
gastric cancer. Nat Rev Gastroenterol Hepatol. 11:664–674. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cao Y and Zhang L: A Smurf1 tale: Function
and regulation of an ubiquitin ligase in multiple cellular
networks. Cell Mol Life Sci. 70:2305–2317. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kwon A, Lee HL, Woo KM, Ryoo HM and Baek
JH: SMURF1 plays a role in EGF-induced breast cancer cell migration
and invasion. Mol Cells. 36:548–555. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang X, Jin C, Tang Y, Tang LY and Zhang
YE: Ubiquitination of tumor necrosis factor receptor-associated
factor 4 (TRAF4) by Smad ubiquitination regulatory factor 1
(Smurf1) regulates motility of breast epithelial and cancer cells.
J Biol Chem. 288:21784–21792. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Suzuki A, Shibata T, Shimada Y, Murakami
Y, Horii A, Shiratori K, Hirohashi S, Inazawa J and Imoto I:
Identification of SMURF1 as a possible target for 7q21.3–22.1
amplification detected in a pancreatic cancer cell line by in-house
array-based comparative genomic hybridization. Cancer Sci.
99:986–994. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kwei KA, Shain AH, Bair R, Montgomery K,
Karikari CA, van de Rijn M, Hidalgo M, Maitra A, Bashyam MD and
Pollack JR: SMURF1 amplification promotes invasiveness in
pancreatic cancer. PLoS One. 6:e239242011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xie P, Zhang M, He S, Lu K, Chen Y, Xing
G, Lu Y, Liu P, Li Y, Wang S, et al: The covalent modifier Nedd8 is
critical for the activation of Smurf1 ubiquitin ligase in
tumorigenesis. Nat Commun. 5:37332014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu C, Billadeau DD, Abdelhakim H, Leof E,
Kaibuchi K, Bernabeu C, Bloom GS, Yang L, Boardman L, Shah VH, et
al: IQGAP1 suppresses TβRII-mediated myofibroblastic activation and
metastatic growth in liver. J Clin Invest. 123:1138–1156. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nie J, Liu L, Xing G, Zhang M, Wei R, Guo
M, Li X, Xie P, Li L, He F, et al: CKIP-1 acts as a colonic tumor
suppressor by repressing oncogenic Smurf1 synthesis and promoting
Smurf1 autodegradation. Oncogene. 33:3677–3687. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang W, Ren F, Wu Q, Jiang D, Li H, Peng
Z, Wang J and Shi H: MicroRNA-497 inhibition of ovarian cancer cell
migration and invasion through targeting of SMAD specific E3
ubiquitin protein ligase 1. Biochem Biophys Res Commun.
449:432–437. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Johansson E, Zhai Q, Zeng ZJ, Yoshida T
and Funa K: Nuclear receptor TLX inhibits TGF-β signaling in
glioblastoma. Exp Cell Res. 343:118–125. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li X, Dai X, Wan L, Inuzuka H, Sun L and
North BJ: Smurf1 regulation of DAB2IP controls cell proliferation
and migration. Oncotarget. 7:26057–26069. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mendonsa AM, VanSaun MN, Ustione A, Piston
DW, Fingleton BM and Gorden DL: Host and tumor derived MMP13
regulate extravasation and establishment of colorectal metastases
in the liver. Mol Cancer. 14:492015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liu L, Xu C, Hsieh JT, Gong J and Xie D:
DAB2IP in cancer. Oncotarget. 7:3766–3776. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu SQ, Yu JP, Yu HG, Lv P and Chen HL:
Activation of Akt and ERK signalling pathways induced by etoposide
confer chemoresistance in gastric cancer cells. Dig Liver Dis.
38:310–318. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yuan D, Xia H, Zhang Y, Chen L, Leng W,
Chen T, Chen Q, Tang Q, Mo X, Liu M, et al: P-Akt/miR-200 signaling
regulates epithelial-mesenchymal transition, migration and invasion
in circulating gastric tumor cells. Int J Oncol. 45:2430–2438.
2014.PubMed/NCBI
|
|
20
|
Tsai YS, Lai CL, Lai CH, Chang KH, Wu K,
Tseng SF, Fazli L, Gleave M, Xiao G, Gandee L, et al: The role of
homeostatic regulation between tumor suppressor DAB2IP and
oncogenic Skp2 in prostate cancer growth. Oncotarget. 5:6425–6436.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen H, Toyooka S, Gazdar AF and Hsieh JT:
Epigenetic regulation of a novel tumor suppressor gene
(hDAB2IP) in prostate cancer cell lines. J Biol Chem.
278:3121–3130. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen H, Tu SW and Hsieh JT:
Down-regulation of human DAB2IP gene expression mediated by
polycomb Ezh2 complex and histone deacetylase in prostate cancer. J
Biol Chem. 280:22437–22444. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Huang J, Wang B, Hui K, Zeng J, Fan J,
Wang X, Hsieh JT, He D and Wu K: miR-92b targets DAB2IP to promote
EMT in bladder cancer migration and invasion. Oncol Rep.
36:1693–1701. 2016.PubMed/NCBI
|
|
24
|
Xiong J, Li Z, Zhang Y, Li D, Zhang G, Luo
X, Jie Z, Liu Y, Cao Y, Le Z, et al: PRL-3 promotes the peritoneal
metastasis of gastric cancer through the PI3K/Akt signaling pathway
by regulating PTEN. Oncol Rep. 36:1819–1828. 2016.PubMed/NCBI
|
|
25
|
Shen X, Si Y, Wang Z, Wang J, Guo Y and
Zhang X: Quercetin inhibits the growth of human gastric cancer stem
cells by inducing mitochondrial-dependent apoptosis through the
inhibition of PI3K/Akt signaling. Int J Mol Med. 38:619–626.
2016.PubMed/NCBI
|
